Home Healthcare Biotechnology Vaccines Market

Vaccines Market Size, Share & Trends Analysis Report By Type (Monovalent, Multivalent), By Route of Administration (Oral, Parenteral, Nasal), By Disease Indication (Viral, Bacterial), By Age Group (Pediatric, Adult) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 04, 2026 | Author: Mitiksha Koul | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Vaccines Market Size Analysis
    1. Introduction
    2. Vaccines Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Monovalent
      2. Multivalent
    3. Vaccines Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Parenteral
      3. Nasal
    4. Vaccines Market Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
      1. Viral
        1. Hepatitis Vaccine
        2. Influenza Vaccine
        3. Human Papillomavirus (HPV) Vaccine
        4. Rotavirus Vaccine (RV)
        5. Polio Vaccine
        6. Varicella Vaccine
        7. COVID-19 Vaccine
        8. Measles, Mumps and Rubella (MMR) Vaccine
        9. Other Vaccines
      2. Bacterial
        1. Pneumococcal Conjugate Vaccine (PCV)
        2. Meningococcal Vaccine
        3. Diphtheria, Tetanus, and Pertussis Vaccines
        4. Other Vaccines
    5. Vaccines Market Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
      1. Pediatric
      2. Adult
  7. North America Vaccines Market Size Analysis
    1. Introduction
    2. Vaccines Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Monovalent
      2. Multivalent
    3. Vaccines Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Parenteral
      3. Nasal
    4. Vaccines Market Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
      1. Viral
        1. Hepatitis Vaccine
        2. Influenza Vaccine
        3. Human Papillomavirus (HPV) Vaccine
        4. Rotavirus Vaccine (RV)
        5. Polio Vaccine
        6. Varicella Vaccine
        7. COVID-19 Vaccine
        8. Measles, Mumps and Rubella (MMR) Vaccine
        9. Other Vaccines
      2. Bacterial
        1. Pneumococcal Conjugate Vaccine (PCV)
        2. Meningococcal Vaccine
        3. Diphtheria, Tetanus, and Pertussis Vaccines
        4. Other Vaccines
    5. Vaccines Market Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
      1. Pediatric
      2. Adult
    6. U.S.
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    7. Canada
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
  8. Europe Vaccines Market Size Analysis
    1. Introduction
    2. Vaccines Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Monovalent
      2. Multivalent
    3. Vaccines Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Parenteral
      3. Nasal
    4. Vaccines Market Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
      1. Viral
        1. Hepatitis Vaccine
        2. Influenza Vaccine
        3. Human Papillomavirus (HPV) Vaccine
        4. Rotavirus Vaccine (RV)
        5. Polio Vaccine
        6. Varicella Vaccine
        7. COVID-19 Vaccine
        8. Measles, Mumps and Rubella (MMR) Vaccine
        9. Other Vaccines
      2. Bacterial
        1. Pneumococcal Conjugate Vaccine (PCV)
        2. Meningococcal Vaccine
        3. Diphtheria, Tetanus, and Pertussis Vaccines
        4. Other Vaccines
    5. Vaccines Market Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
      1. Pediatric
      2. Adult
    6. U.K.
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    7. Germany
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    8. France
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    9. Spain
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    10. Italy
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    11. Russia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    12. Nordic
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    13. Benelux
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    14. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
  9. APAC Vaccines Market Size Analysis
    1. Introduction
    2. Vaccines Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Monovalent
      2. Multivalent
    3. Vaccines Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Parenteral
      3. Nasal
    4. Vaccines Market Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
      1. Viral
        1. Hepatitis Vaccine
        2. Influenza Vaccine
        3. Human Papillomavirus (HPV) Vaccine
        4. Rotavirus Vaccine (RV)
        5. Polio Vaccine
        6. Varicella Vaccine
        7. COVID-19 Vaccine
        8. Measles, Mumps and Rubella (MMR) Vaccine
        9. Other Vaccines
      2. Bacterial
        1. Pneumococcal Conjugate Vaccine (PCV)
        2. Meningococcal Vaccine
        3. Diphtheria, Tetanus, and Pertussis Vaccines
        4. Other Vaccines
    5. Vaccines Market Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
      1. Pediatric
      2. Adult
    6. China
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    7. Korea
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    8. Japan
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    9. India
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    10. Australia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    11. Taiwan
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    12. South East Asia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    13. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
  10. Middle East and Africa Vaccines Market Size Analysis
    1. Introduction
    2. Vaccines Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Monovalent
      2. Multivalent
    3. Vaccines Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Parenteral
      3. Nasal
    4. Vaccines Market Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
      1. Viral
        1. Hepatitis Vaccine
        2. Influenza Vaccine
        3. Human Papillomavirus (HPV) Vaccine
        4. Rotavirus Vaccine (RV)
        5. Polio Vaccine
        6. Varicella Vaccine
        7. COVID-19 Vaccine
        8. Measles, Mumps and Rubella (MMR) Vaccine
        9. Other Vaccines
      2. Bacterial
        1. Pneumococcal Conjugate Vaccine (PCV)
        2. Meningococcal Vaccine
        3. Diphtheria, Tetanus, and Pertussis Vaccines
        4. Other Vaccines
    5. Vaccines Market Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
      1. Pediatric
      2. Adult
    6. UAE
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    7. Turkey
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    8. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    9. South Africa
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    10. Egypt
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    11. Nigeria
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    12. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
  11. LATAM Vaccines Market Size Analysis
    1. Introduction
    2. Vaccines Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Monovalent
      2. Multivalent
    3. Vaccines Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Parenteral
      3. Nasal
    4. Vaccines Market Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
      1. Viral
        1. Hepatitis Vaccine
        2. Influenza Vaccine
        3. Human Papillomavirus (HPV) Vaccine
        4. Rotavirus Vaccine (RV)
        5. Polio Vaccine
        6. Varicella Vaccine
        7. COVID-19 Vaccine
        8. Measles, Mumps and Rubella (MMR) Vaccine
        9. Other Vaccines
      2. Bacterial
        1. Pneumococcal Conjugate Vaccine (PCV)
        2. Meningococcal Vaccine
        3. Diphtheria, Tetanus, and Pertussis Vaccines
        4. Other Vaccines
    5. Vaccines Market Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
      1. Pediatric
      2. Adult
    6. Brazil
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    7. Mexico
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    8. Argentina
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    9. Chile
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    10. Colombia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
    11. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Monovalent
        2. Multivalent
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
        3. Nasal
      4. Market Size & Forecast By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. Hepatitis Vaccine
          2. Influenza Vaccine
          3. Human Papillomavirus (HPV) Vaccine
          4. Rotavirus Vaccine (RV)
          5. Polio Vaccine
          6. Varicella Vaccine
          7. COVID-19 Vaccine
          8. Measles, Mumps and Rubella (MMR) Vaccine
          9. Other Vaccines
        2. Bacterial
          1. Pneumococcal Conjugate Vaccine (PCV)
          2. Meningococcal Vaccine
          3. Diphtheria, Tetanus, and Pertussis Vaccines
          4. Other Vaccines
      5. Market Size & Forecast By Age Group 2022-2034 (USD MILLION/ Units)
        1. Pediatric
        2. Adult
  12. Competitive Landscape
    1. Vaccines Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Pfizer Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Moderna, Inc.
    3. Merck & Co., Inc.
    4. GSK plc
    5. Sanofi
    6. BioNTech SE. 
    7. Johnson & Johnson
    8. China National Biotec Group Company Limited (CNBG)
    9. AstraZeneca
    10. Serum Institute of India (SII)
    11. Bejing
    12. CSL Behring
    13. Walvax Biotechnology Co., Ltd. 
    14. Bavarian Nordic Inc.
    15. Takeda Pharmaceutical Company Limited
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.